Search filters

List of works by Christopher P Fox

A mutation in X-linked inhibitor of apoptosis (G466X) leads to memory inflation of Epstein-Barr virus-specific T cells

scientific article published on December 2014

A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy

scientific article published on 29 July 2010

A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs.

scientific article

A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL

article

Acute disseminated encephalomyelitis following allo-SCT: central nervous system manifestation of GVHD

scientific article published on 17 March 2014

Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study

scientific article published on 16 August 2020

Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK inhibition as an Effective Strategy

scientific article published on 20 March 2020

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.

scientific article

Complete remission of immunochemotherapy-refractory monomorphic post-transplant lymphoproliferative disorder mediated by endogenous T-cell recovery

scientific article published on 05 February 2019

Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations

scientific article published on 7 September 2011

Delineating outcomes of patients with diffuse large b cell lymphoma using the national comprehensive cancer network-international prognostic index and positron emission tomography-defined remission status; a population-based analysis

scientific article

Does end-of-treatment FDG-PET provide any additional prognostic value to the pre-treatment NCCN-IPI score? Reply to Adams and Kwee.

scientific article published on 28 March 2016

EBV meets its match

scientific article published on 01 February 2010

EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era.

scientific article published on 11 November 2013

EBV-driven relapse of peripheral T-cell lymphoma, masquerading as a post transplant lymphoproliferative disorder following allo-SCT.

scientific article

Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post-BCR inhibitor setting: a UK wide analysis

Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy

scientific article published on 06 September 2018

Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults characterized by high viral genome load within circulating natural killer cells.

scientific article published in July 2010

Epstein-barr virus and the pathogenesis of T and NK lymphoma: a mystery unsolved.

scientific article published on December 2012

Epstein–Barr Virus and Infectious Mononucleosis: What Students Can Teach Us ⬇️

scientific article published on October 24, 2012

Era-by-era improvement in survival for elderly patients with Hodgkin lymphoma; outcome data from a large population-based cohort

scientific article published on 15 September 2015

Follicular helper T-cells: expanding roles in T-cell lymphoma and targets for treatment.

scientific article published on 12 May 2014

Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT. ⬇️

scientific article

Guideline for the treatment of chronic lymphocytic leukaemia: A British Society for Haematology Guideline

scientific article published on 15 July 2018

Guidelines for the diagnosis and management of primary central nervous system diffuse large B-cell lymphoma

scientific article published on 23 November 2018

Haematological malignancies presenting with acute liver injury: a single-centre experience.

scientific article published on 23 September 2008

High-dose chemotherapy and autologous stem cell transplantation for primary central nervous system lymphoma: a multi-centre retrospective analysis from the United Kingdom

scientific article published on 05 June 2017

High-dose therapy and autologous stem cell transplantation for extra-nodal NK/T lymphoma in patients from the Western hemisphere: a study from the European Society for Blood and Marrow Transplantation

scientific article published on 22 April 2015

High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study

scientific article published on 24 April 2017

IVE (ifosfamide, epirubicin and etoposide) is a more effective stem cell mobilisation regimen than ICE (ifosphamide, carboplatin and etoposide) in the context of salvage therapy for lymphoma.

scientific article

Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study

scientific article published on 11 July 2019

Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia

scientific article published on 07 November 2019

Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

scientific article published on 04 May 2018

Idelalisib-Rituximab induces clinical remissions in patients with TP53 disrupted B cell prolymphocytic leukaemia.

scientific article published on 7 April 2016

Idelalisib-rituximab induces durable remissions in TP53 disrupted B-PLL but results in significant toxicity: updated results of the UK-wide compassionate use programme.

scientific article published on 22 February 2018

Immunotherapy for Epstein-Barr virus-associated malignancies.

scientific article published on May 2010

Impact of Pretransplantation (18)F-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin Lymphoma

scientific article published on 14 April 2016

Impact of intended and relative dose intensity of R-CHOP in a large, consecutive cohort of elderly diffuse large B-cell lymphoma patients treated with curative intent: no difference in cumulative incidence of relapse comparing patients by age

scientific article published on 11 April 2019

Kinetics of T-cell subset reconstitution following treatment with bendamustine and rituximab for low-grade lymphoproliferative disease: a population-based analysis

scientific article published on 13 December 2018

Low dose erythropoietin is effective in reducing transfusion requirements following allogeneic HSCT.

scientific article published in December 2005

Male gender is an independent predictor for worse survival and relapse in a large, consecutive cohort of elderly DLBCL patients treated with R-CHOP

scientific article published on 24 April 2019

Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines

scientific article

Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event

scientific article published on 8 October 2015

NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome

scientific article published on 5 July 2016

Non-uniform in vivo Expansion of Epstein-Barr Virus-Specific T-Cells Following Donor Lymphocyte Infusion for Post-transplant Lymphoproliferative Disease

scientific article published on 29 October 2019

Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival

scientific article published on 31 March 2020

Paraneoplastic erythroderma: unusual presentation secondary to diffuse large B cell lymphoma

scientific article published on 30 May 2019

Primary CNS lymphoma

scientific article published on 01 September 2014

Prognostic Factors for Complete Response to Ibrutinib in Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of 2 Clinical Trials

scientific article published on 22 February 2018

Refining CNS relapse risk in DLBCL: easy as ABC?

scientific article published on 01 February 2019

Refractoriness to rituximab-based therapy and elevated serum B2-microglobulin predict for inferior survival in marginal zone lymphoma

scientific article published on 03 April 2019

Rituximab in primary central nervous system lymphoma-A systematic review and meta-analysis

scientific article published on 09 October 2019

Single-center Series of Bone Marrow Biopsy-Defined Large Granular Lymphocyte Leukemia: High Rates of Sustained Response to Oral Methotrexate.

scientific article

Stand-alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R-CHOP and is associated increased infection-related toxicity

scientific article published on 20 June 2019

The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia

scientific article published on 04 November 2019

The role of high-dose chemotherapy and autologous stem cell transplant for treatment-naΪve patients with peripheral T-cell lymphoma: a systematic review of the literature

scientific article published on 05 May 2016

Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice

scientific article published on 19 April 2019

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extran

scientific article published on 17 October 2017

Paulina is supported by:

About Paulina

Help